Literature DB >> 30314946

MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.

Bo Liu1, Yu Hu2, Lu Qin3, Xu-Bin Peng4, Ya-Xun Huang5.   

Abstract

BACKGROUND: Cholangiocarcinoma (CCA) represents a devastating malignancy characterized by high mortality, and notoriously problematic to diagnose. Recently, microRNAs (miRs) have been intensively investigated due to their potential usefulness from a tumor treatment perspective. AIMS: The current study was aimed to investigate whether miR-494 influences epithelial-mesenchymal transition (EMT), tumor growth and metastasis of CCA.
METHODS: The regulatory miRNAs of WDHD1 in CCA expression chip were predicted, followed by determination of the miR-494 and WDHD1 expression in normal cholangiocyte tissues and CCA tissues. The related protein levels were determined. CCA cell migration, invasion, viability, and cell cycle distribution and the dosage-dependent effect of miR-494 on CCA cell growth were subsequently detected. Finally, tumorigenicity and lymph node metastasis (LNM) were measured.
RESULTS: Initially, miR-194 affected the CCA development via negatively regulating WDHD1 and miR-494 which were downregulated while WDHD1 was upregulated in CCA. In addition, miR-494 overexpression elevated E-cadherin expression while decreased expressions of WDHD1, N-cadherin, Vimentin, Snail, Twist and MMP-9. Finally, overexpressed miR-494 was observed to suppress EMT, cell viability, migration, invasion, arrest cell cycle progression, tumor formation, and LNM while accelerating cell apoptosis in vivo.
CONCLUSION: This study indicated that miR-494 overexpression suppresses EMT, tumor formation and LNM while promoting CCA cell apoptosis through inhibiting WDHD1 in CCA.
Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Epithelial-mesenchymal transition; Lymph node metastasis; MicroRNA-494; WDHD1

Mesh:

Substances:

Year:  2018        PMID: 30314946     DOI: 10.1016/j.dld.2018.08.021

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  8 in total

Review 1.  Cholangiocarcinoma: novel therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Domenico Alvaro; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2020-02-26       Impact factor: 6.902

2.  And-1 Coordinates with the FANCM Complex to Regulate Fanconi Anemia Signaling and Cisplatin Resistance.

Authors:  Yi Zhang; Jing Li; Yuan Zhou; Zhuqing Li; Changmin Peng; Huadong Pei; Wenge Zhu
Journal:  Cancer Res       Date:  2022-09-16       Impact factor: 13.312

Review 3.  The Involvement of WDHD1 in the Occurrence of Esophageal Cancer as a Downstream Target of PI3K/AKT Pathway.

Authors:  Qingying Xian; Danxia Zhu
Journal:  J Oncol       Date:  2022-04-05       Impact factor: 4.375

4.  Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.

Authors:  Shuoling Chen; Chang Gao; Yangyuan Wu; Zunnan Huang
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

5.  STAT3 plays an important role in DNA replication by turning on WDHD1.

Authors:  Yunying Zhou; Jason J Chen
Journal:  Cell Biosci       Date:  2021-01-07       Impact factor: 7.133

6.  WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer.

Authors:  Ayse Ertay; Huiquan Liu; Dian Liu; Ping Peng; Charlotte Hill; Hua Xiong; David Hancock; Xianglin Yuan; Marcin R Przewloka; Mark Coldwell; Michael Howell; Paul Skipp; Rob M Ewing; Julian Downward; Yihua Wang
Journal:  Cell Death Dis       Date:  2020-11-21       Impact factor: 8.469

7.  Identification of Survival-Associated Hub Genes in Pancreatic Adenocarcinoma Based on WGCNA.

Authors:  Liya Huang; Ting Ye; Jingjing Wang; Xiaojing Gu; Ruiting Ma; Lulu Sheng; Binwu Ma
Journal:  Front Genet       Date:  2022-01-03       Impact factor: 4.599

8.  Parental histone deposition on the replicated strands promotes error-free DNA damage tolerance and regulates drug resistance.

Authors:  Valeria Dolce; Sabrina Dusi; Michele Giannattasio; Chinnu Rose Joseph; Marco Fumasoni; Dana Branzei
Journal:  Genes Dev       Date:  2022-02-03       Impact factor: 12.890

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.